Anticoagulants Market Key Players Analysis 2031
MARKET OVERVIEW
Anticoagulant drugs (sometimes called blood thinners) are chemical substances that prevent or decrease blood coagulation and prolong the time it takes for blood to clot. These drugs are primarily used to prevent blood clots in patients with atrial fibrillation, deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and other medical conditions. The global anticoagulants market is expected to rise significantly over the forecast period, in respect to growing prevalence of venous thromboembolism (VTE) and cardiovascular disorders, increased adoption of novel oral anticoagulants (NOACs), and rising awareness of NOACs in developing countries.
MARKET SCOPE
The "Global Anticoagulants Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the anticoagulants market with detailed market segmentation by drug class, route of administration, application and distribution channel. The report provides key statistics on the market status of the leading anticoagulants market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on drug class the market is segmented as, novel oral anticoagulants (NOACs), heparin & low-molecular-weight heparin (LMWH), vitamin K antagonist and others.
- Based on route of administration the market is segmented as, oral anticoagulant and injectable anticoagulant.
- Based on application the market is segmented as, atrial fibrillation & heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE) and others.
- Based on distribution channel the market is segmented as, hospital pharmacies, retail pharmacies and online pharmacies.
MARKET DYNAMICS
Drivers:
- Growing prevalence of venous thromboembolism (VTE) and cardiovascular disorders.
- Increased adoption of novel oral anticoagulants (NOACs), and rising awareness of NOACs in developing countries.
- Surge in demand for novel therapeutics along with growing elderly population are also expected to fuel the market growth.
Restraints:
- However, stringent regulatory approvals and chances of side effects from treatment are expect to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The anticoagulants market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the anticoagulants market in these regions. Mrinal Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
IMPACT OF COVID-19 ON ANTICOAGULANTS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Have a question?
Speak to Analyst
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The anticoagulants market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the anticoagulants market in these regions.
IMPACT OF COVID-19 ON ANTICOAGULANTS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the anticoagulants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from anticoagulants market are anticipated to lucrative growth opportunities in the future with the rising demand for anticoagulants in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the anticoagulants market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc.
- Pfizer, Inc.
- Sanofi
- Aspen Holdings
- Janssen Pharmaceuticals, Inc
- Boehringer Ingelheim International GmbH
- DAIICHI SANKYO COMPANY, LIMITED
- Alexion Pharmaceuticals, Inc
- Bayer AG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anticoagulants Market - By Drug Class
1.3.2 Anticoagulants Market - By Route Of Administration
1.3.3 Anticoagulants Market - By Application
1.3.4 Anticoagulants Market - By Distribution Channel
1.3.5 Anticoagulants Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTICOAGULANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. ANTICOAGULANTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTICOAGULANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTICOAGULANTS - GLOBAL MARKET OVERVIEW
6.2. ANTICOAGULANTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. NOVEL ORAL ANTICOAGULANTS (NOACS)
7.3.1. Overview
7.3.2. Novel oral anticoagulants (NOACs) Market Forecast and Analysis
7.4. HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN (LMWH)
7.4.1. Overview
7.4.2. Heparin and Low-molecular-weight heparin (LMWH) Market Forecast and Analysis
7.5. VITAMIN K ANTAGONIST
7.5.1. Overview
7.5.2. Vitamin K Antagonist Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL ANTICOAGULANT
8.3.1. Overview
8.3.2. Oral anticoagulant Market Forecast and Analysis
8.4. INJECTABLE ANTICOAGULANT
8.4.1. Overview
8.4.2. Injectable anticoagulant Market Forecast and Analysis
9. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ATRIAL FIBRILLATION AND HEART ATTACK
9.3.1. Overview
9.3.2. Atrial fibrillation and Heart Attack Market Forecast and Analysis
9.4. STROKE
9.4.1. Overview
9.4.2. Stroke Market Forecast and Analysis
9.5. DEEP VEIN THROMBOSIS (DVT)
9.5.1. Overview
9.5.2. Deep Vein Thrombosis (DVT) Market Forecast and Analysis
9.6. PULMONARY EMBOLISM (PE)
9.6.1. Overview
9.6.2. Pulmonary Embolism (PE) Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis
11. ANTICOAGULANTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Anticoagulants Market Overview
11.1.2 North America Anticoagulants Market Forecasts and Analysis
11.1.3 North America Anticoagulants Market Forecasts and Analysis - By Drug Class
11.1.4 North America Anticoagulants Market Forecasts and Analysis - By Route Of Administration
11.1.5 North America Anticoagulants Market Forecasts and Analysis - By Application
11.1.6 North America Anticoagulants Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Anticoagulants Market Forecasts and Analysis - By Countries
11.1.7.1 United States Anticoagulants Market
11.1.7.1.1 United States Anticoagulants Market by Drug Class
11.1.7.1.2 United States Anticoagulants Market by Route Of Administration
11.1.7.1.3 United States Anticoagulants Market by Application
11.1.7.1.4 United States Anticoagulants Market by Distribution Channel
11.1.7.2 Canada Anticoagulants Market
11.1.7.2.1 Canada Anticoagulants Market by Drug Class
11.1.7.2.2 Canada Anticoagulants Market by Route Of Administration
11.1.7.2.3 Canada Anticoagulants Market by Application
11.1.7.2.4 Canada Anticoagulants Market by Distribution Channel
11.1.7.3 Mexico Anticoagulants Market
11.1.7.3.1 Mexico Anticoagulants Market by Drug Class
11.1.7.3.2 Mexico Anticoagulants Market by Route Of Administration
11.1.7.3.3 Mexico Anticoagulants Market by Application
11.1.7.3.4 Mexico Anticoagulants Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Anticoagulants Market Overview
11.2.2 Europe Anticoagulants Market Forecasts and Analysis
11.2.3 Europe Anticoagulants Market Forecasts and Analysis - By Drug Class
11.2.4 Europe Anticoagulants Market Forecasts and Analysis - By Route Of Administration
11.2.5 Europe Anticoagulants Market Forecasts and Analysis - By Application
11.2.6 Europe Anticoagulants Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Anticoagulants Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Anticoagulants Market
11.2.7.1.1 Germany Anticoagulants Market by Drug Class
11.2.7.1.2 Germany Anticoagulants Market by Route Of Administration
11.2.7.1.3 Germany Anticoagulants Market by Application
11.2.7.1.4 Germany Anticoagulants Market by Distribution Channel
11.2.7.2 France Anticoagulants Market
11.2.7.2.1 France Anticoagulants Market by Drug Class
11.2.7.2.2 France Anticoagulants Market by Route Of Administration
11.2.7.2.3 France Anticoagulants Market by Application
11.2.7.2.4 France Anticoagulants Market by Distribution Channel
11.2.7.3 Italy Anticoagulants Market
11.2.7.3.1 Italy Anticoagulants Market by Drug Class
11.2.7.3.2 Italy Anticoagulants Market by Route Of Administration
11.2.7.3.3 Italy Anticoagulants Market by Application
11.2.7.3.4 Italy Anticoagulants Market by Distribution Channel
11.2.7.4 Spain Anticoagulants Market
11.2.7.4.1 Spain Anticoagulants Market by Drug Class
11.2.7.4.2 Spain Anticoagulants Market by Route Of Administration
11.2.7.4.3 Spain Anticoagulants Market by Application
11.2.7.4.4 Spain Anticoagulants Market by Distribution Channel
11.2.7.5 United Kingdom Anticoagulants Market
11.2.7.5.1 United Kingdom Anticoagulants Market by Drug Class
11.2.7.5.2 United Kingdom Anticoagulants Market by Route Of Administration
11.2.7.5.3 United Kingdom Anticoagulants Market by Application
11.2.7.5.4 United Kingdom Anticoagulants Market by Distribution Channel
11.2.7.6 Rest of Europe Anticoagulants Market
11.2.7.6.1 Rest of Europe Anticoagulants Market by Drug Class
11.2.7.6.2 Rest of Europe Anticoagulants Market by Route Of Administration
11.2.7.6.3 Rest of Europe Anticoagulants Market by Application
11.2.7.6.4 Rest of Europe Anticoagulants Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Anticoagulants Market Overview
11.3.2 Asia-Pacific Anticoagulants Market Forecasts and Analysis
11.3.3 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Drug Class
11.3.4 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Route Of Administration
11.3.5 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Anticoagulants Market
11.3.7.1.1 Australia Anticoagulants Market by Drug Class
11.3.7.1.2 Australia Anticoagulants Market by Route Of Administration
11.3.7.1.3 Australia Anticoagulants Market by Application
11.3.7.1.4 Australia Anticoagulants Market by Distribution Channel
11.3.7.2 China Anticoagulants Market
11.3.7.2.1 China Anticoagulants Market by Drug Class
11.3.7.2.2 China Anticoagulants Market by Route Of Administration
11.3.7.2.3 China Anticoagulants Market by Application
11.3.7.2.4 China Anticoagulants Market by Distribution Channel
11.3.7.3 India Anticoagulants Market
11.3.7.3.1 India Anticoagulants Market by Drug Class
11.3.7.3.2 India Anticoagulants Market by Route Of Administration
11.3.7.3.3 India Anticoagulants Market by Application
11.3.7.3.4 India Anticoagulants Market by Distribution Channel
11.3.7.4 Japan Anticoagulants Market
11.3.7.4.1 Japan Anticoagulants Market by Drug Class
11.3.7.4.2 Japan Anticoagulants Market by Route Of Administration
11.3.7.4.3 Japan Anticoagulants Market by Application
11.3.7.4.4 Japan Anticoagulants Market by Distribution Channel
11.3.7.5 South Korea Anticoagulants Market
11.3.7.5.1 South Korea Anticoagulants Market by Drug Class
11.3.7.5.2 South Korea Anticoagulants Market by Route Of Administration
11.3.7.5.3 South Korea Anticoagulants Market by Application
11.3.7.5.4 South Korea Anticoagulants Market by Distribution Channel
11.3.7.6 Rest of Asia-Pacific Anticoagulants Market
11.3.7.6.1 Rest of Asia-Pacific Anticoagulants Market by Drug Class
11.3.7.6.2 Rest of Asia-Pacific Anticoagulants Market by Route Of Administration
11.3.7.6.3 Rest of Asia-Pacific Anticoagulants Market by Application
11.3.7.6.4 Rest of Asia-Pacific Anticoagulants Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Anticoagulants Market Overview
11.4.2 Middle East and Africa Anticoagulants Market Forecasts and Analysis
11.4.3 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Drug Class
11.4.4 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Route Of Administration
11.4.5 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Anticoagulants Market
11.4.7.1.1 South Africa Anticoagulants Market by Drug Class
11.4.7.1.2 South Africa Anticoagulants Market by Route Of Administration
11.4.7.1.3 South Africa Anticoagulants Market by Application
11.4.7.1.4 South Africa Anticoagulants Market by Distribution Channel
11.4.7.2 Saudi Arabia Anticoagulants Market
11.4.7.2.1 Saudi Arabia Anticoagulants Market by Drug Class
11.4.7.2.2 Saudi Arabia Anticoagulants Market by Route Of Administration
11.4.7.2.3 Saudi Arabia Anticoagulants Market by Application
11.4.7.2.4 Saudi Arabia Anticoagulants Market by Distribution Channel
11.4.7.3 U.A.E Anticoagulants Market
11.4.7.3.1 U.A.E Anticoagulants Market by Drug Class
11.4.7.3.2 U.A.E Anticoagulants Market by Route Of Administration
11.4.7.3.3 U.A.E Anticoagulants Market by Application
11.4.7.3.4 U.A.E Anticoagulants Market by Distribution Channel
11.4.7.4 Rest of Middle East and Africa Anticoagulants Market
11.4.7.4.1 Rest of Middle East and Africa Anticoagulants Market by Drug Class
11.4.7.4.2 Rest of Middle East and Africa Anticoagulants Market by Route Of Administration
11.4.7.4.3 Rest of Middle East and Africa Anticoagulants Market by Application
11.4.7.4.4 Rest of Middle East and Africa Anticoagulants Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Anticoagulants Market Overview
11.5.2 South and Central America Anticoagulants Market Forecasts and Analysis
11.5.3 South and Central America Anticoagulants Market Forecasts and Analysis - By Drug Class
11.5.4 South and Central America Anticoagulants Market Forecasts and Analysis - By Route Of Administration
11.5.5 South and Central America Anticoagulants Market Forecasts and Analysis - By Application
11.5.6 South and Central America Anticoagulants Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Anticoagulants Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Anticoagulants Market
11.5.7.1.1 Brazil Anticoagulants Market by Drug Class
11.5.7.1.2 Brazil Anticoagulants Market by Route Of Administration
11.5.7.1.3 Brazil Anticoagulants Market by Application
11.5.7.1.4 Brazil Anticoagulants Market by Distribution Channel
11.5.7.2 Argentina Anticoagulants Market
11.5.7.2.1 Argentina Anticoagulants Market by Drug Class
11.5.7.2.2 Argentina Anticoagulants Market by Route Of Administration
11.5.7.2.3 Argentina Anticoagulants Market by Application
11.5.7.2.4 Argentina Anticoagulants Market by Distribution Channel
11.5.7.3 Rest of South and Central America Anticoagulants Market
11.5.7.3.1 Rest of South and Central America Anticoagulants Market by Drug Class
11.5.7.3.2 Rest of South and Central America Anticoagulants Market by Route Of Administration
11.5.7.3.3 Rest of South and Central America Anticoagulants Market by Application
11.5.7.3.4 Rest of South and Central America Anticoagulants Market by Distribution Channel
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANTICOAGULANTS MARKET, KEY COMPANY PROFILES
13.1. BRISTOL-MYERS SQUIBB COMPANY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GLAXOSMITHKLINE PLC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PFIZER, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SANOFI
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ASPEN HOLDINGS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. JANSSEN PHARMACEUTICALS, INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. DAIICHI SANKYO COMPANY, LIMITED
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ALEXION PHARMACEUTICALS, INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BAYER AG
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc.
- Pfizer, Inc.
- Sanofi
- Aspen Holdings
- Janssen Pharmaceuticals, Inc
- Boehringer Ingelheim International GmbH
- DAIICHI SANKYO COMPANY, LIMITED
- Alexion Pharmaceuticals, Inc
- Bayer AG
- Sun Pharmaceuticals
- Dr. Reddy's Laboratories Ltd
- Abbott
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For